Key result
ECMO linked to favorable survival rates in the treatment of fulminant myocarditis.
Why the study?
Fulminant myocarditis can rapidly deteriorate into cardiogenic shock or electrical storm often requiring mechanical circulatory support, and increasing studies investigate the application of extracorporeal membrane oxygenation in these patients.
Does extracorporeal membrane oxygenation (ECMO) improve survival in patients with fulminant myocarditis?
Does extracorporeal membrane oxygenation (ECMO) improve survival in patients with fulminant myocarditis?
ECMO is a viable mechanical circulatory support option that provides good survival rates for patients with fulminant myocarditis experiencing cardiogenic shock or electrical storm.
May support ECMO consideration in fulminant myocarditis shock; leaves open need for prospective trials.
Fulminant myocarditis (FM) is a rare but serious clinical syndrome which can be characterized by the rapid deterioration of cardiac function, with cardiogenic shock (CS) and arrhythmic electrical storms being common presentations, often requiring adjunctive support with mechanical circulatory devices. With the development of mechanical circulatory support (MCS) devices, there are now more and more studies investigating the application of MCS in FM patients, and the use of extracorporeal membrane oxygenation (ECMO) to treat FM has shown good survival rates. This review elucidates the treatment of FM, and the application and clinical outcomes associated with ECMO intervention.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2024) conducted a review in Fulminant myocarditis. Extracorporeal membrane oxygenation (ECMO) was evaluated on Survival rates and clinical outcomes. Extracorporeal membrane oxygenation (ECMO) intervention for the treatment of fulminant myocarditis has shown good survival rates.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: